MMM EBITDA | 3M CO

3M CO (MMM) EBITDA

2026-06-30: Basis Reported; EBITDA $1.32B*; Operating income $984.00M; Depreciation and amortization $335.00M*.
2026-03-31: Basis Reported; EBITDA $1.72B; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $1.23B; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $1.75B*; Operating income $1.45B; Depreciation and amortization $298.00M*.

Complete source-backed ebitda history.

Available history: 2008-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$1.32B*	$984.00M	$335.00M*	$6.50B	20.29%*	$223.00M*	$986.00M*	(m)	(m)	$1.06B	$183.00M
2026-03-31	Reported	$1.72B	(m)	(m)	(m)	28.57%	$225.00M	$574.00M	(m)	(m)	$744.00M	$221.00M
2025-12-31	Reported	$1.23B	(m)	(m)	(m)	19.99%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$1.75B*	$1.45B	$298.00M*	$6.52B	26.78%*	$218.00M*	$1.76B*	(m)	(m)	$820.00M	$308.00M
2025-06-30	Reported	$1.43B*	$1.14B	$290.00M*	$6.34B	22.54%*	$208.00M*	-$954.00M*	(m)	(m)	$1.27B	$245.00M
2025-03-31	Reported	$1.54B	(m)	(m)	(m)	25.80%	$236.00M	-$79.00M	(m)	(m)	$945.00M	$265.00M
2024-12-31	Reported	$1.41B	(m)	(m)	(m)	23.41%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$1.63B*	$1.32B	$310.00M*	$6.29B	25.83%*	$246.00M*	-$1.79B*	(m)	(m)	$1.06B	$348.00M
2024-06-30	Reported	$1.57B*	$1.27B	$301.00M*	$6.25B	25.15%*	$269.00M*	$1.02B*	(m)	(m)	$1.13B	$203.00M
2024-03-31	Reported	$1.58B	(m)	(m)	(m)	26.25%	$375.00M	$767.00M	(m)	(m)	$1.13B	$220.00M
2023-12-31	Reported	$1.44B	(m)	(m)	(m)	23.93%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$2.56B*	-$3.10B	$535.00M*	$6.27B	-40.85%*	$405.00M*	$1.91B*	(m)	(m)	$5.42B	-$777.00M
2023-06-30	Reported	-$8.91B*	-$9.36B	$449.00M*	$6.28B	-141.80%*	$377.00M*	$1.51B*	(m)	(m)	$11.62B	-$2.26B
2023-03-31	Reported	$1.71B	(m)	(m)	(m)	21.26%	$475.00M	$1.27B	(m)	(m)	$1.71B	$210.00M
2022-12-31	Reported	-$1.08B	(m)	(m)	(m)	-9800.00%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$4.61B*	$4.16B	$450.00M*	(m)	(m)	$435.00M*	$1.53B*	(m)	(m)	$2.00B	$271.00M
2022-06-30	Reported	$572.00M*	$110.00M	$462.00M*	(m)	(m)	$384.00M*	$1.13B*	(m)	(m)	$3.02B	-$23.00M
2022-03-31	Reported	$2.1B	(m)	(m)	(m)	23.79%	$424.00M	$1.01B	(m)	(m)	$1.88B	$302.00M
2021-12-31	Reported	$2.12B	(m)	(m)	(m)	24.65%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$2.26B*	$1.79B	$476.00M*	(m)	(m)	$343.00M*	$1.87B*	(m)	(m)	$1.82B	$324.00M
2021-06-30	Reported	$2.44B*	$1.97B	$472.00M*	$8.95B	27.30%*	$394.00M*	$1.89B*	(m)	(m)	$1.75B	$415.00M
2021-03-31	Reported	$2.45B	(m)	(m)	(m)	27.73%	$310.00M	$1.69B	(m)	(m)	$1.81B	$319.00M
2020-12-31	Reported	$2.35B	(m)	(m)	(m)	27.34%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$2.39B*	$1.91B	$481.00M*	$8.35B	28.62%*	$368.00M*	$2.48B*	(m)	(m)	$1.68B	$391.00M
2020-06-30	Reported	$2.23B*	$1.74B	$492.00M*	$7.18B	31.10%*	$379.00M*	$1.91B*	(m)	(m)	$1.59B	$347.00M
2020-03-31	Reported	$2.1B	(m)	(m)	(m)	26.04%	$332.00M	$1.21B	(m)	(m)	$1.77B	$278.00M
2019-12-31	Reported	$1.79B	(m)	(m)	(m)	22.04%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$2.39B*	$2.01B	$379.00M*	$7.99B	29.91%*	$349.00M*	$2.02B*	(m)	(m)	$1.46B	$378.00M
2019-06-30	Reported	$2.08B*	$1.70B	$376.00M*	$8.17B	25.43%*	$421.00M*	$1.66B*	(m)	(m)	$1.69B	$315.00M
2019-03-31	Reported	$1.51B	(m)	(m)	(m)	19.22%	$391.00M	$1.05B	(m)	(m)	$1.95B	$195.00M
2018-12-31	Reported	$2.15B	(m)	(m)	(m)	27.11%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	$2.37B*	$2.02B	$355.00M*	$8.15B	29.08%*	$377.00M*	$2.14B*	(m)	(m)	$1.55B	$419.00M
2018-06-30	Reported	$2.78B*	$2.40B	$380.00M*	$8.39B	33.15%*	$365.00M*	$1.90B*	(m)	(m)	$1.80B	$488.00M
2018-03-31	Reported	$1.39B	(m)	(m)	(m)	16.78%	$304.00M	$143.00M	(m)	(m)	$2.57B	$359.00M
2017-12-31	Reported	$2.14B	(m)	(m)	(m)	26.76%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$2.38B*	$2.01B	$377.00M*	$8.17B	29.19%*	$325.00M*	$1.75B*	(m)	(m)	$1.64B	$564.00M
2017-06-30	Reported	$2.53B*	$2.15B	$380.00M*	$7.81B	32.43%*	$302.00M*	$1.64B*	(m)	(m)	$1.62B	$557.00M
2017-03-31	Reported	$2.18B	(m)	(m)	(m)	28.37%	$287.00M	$988.00M	(m)	(m)	$1.61B	$411.00M
2016-12-31	Reported	$1.85B	(m)	(m)	(m)	25.28%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$2.27B*	$1.90B	$368.00M*	(m)	(m)	$347.00M*	$1.91B*	(m)	(m)	$1.53B	$531.00M
2016-06-30	Reported	$2.23B*	$1.87B	$366.00M*	(m)	(m)	$323.00M*	(m)	(m)	(m)	$1.56B	$542.00M
2016-03-31	Reported	$2.14B	(m)	(m)	(m)	28.94%	$314.00M	(m)	(m)	(m)	$1.49B	$468.00M
2015-12-31	Reported	$1.9B	(m)	(m)	(m)	25.99%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	$2.23B*	$1.88B	$355.00M*	(m)	(m)	$354.00M*	(m)	(m)	(m)	$1.53B	$547.00M
2015-06-30	Reported	$2.18B*	$1.84B	$344.00M*	(m)	(m)	$370.00M*	(m)	(m)	(m)	$1.55B	$509.00M
2015-03-31	Reported	$2.07B	(m)	(m)	(m)	27.30%	$291.00M	(m)	(m)	(m)	$1.56B	$502.00M
2014-12-31	Reported	$2.01B	(m)	(m)	(m)	26.07%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	$2.25B*	$1.90B	$350.00M*	(m)	(m)	$369.00M*	(m)	(m)	(m)	$1.60B	$569.00M
2014-06-30	Reported	$2.21B*	$1.86B	$358.00M*	(m)	(m)	$341.00M*	(m)	(m)	(m)	$1.65B	$537.00M
2014-03-31	Reported	$2.07B	(m)	(m)	(m)	26.38%	$293.00M	(m)	(m)	(m)	$1.63B	$463.00M
2013-12-31	Reported	$1.94B	(m)	(m)	(m)	25.58%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	$2.08B*	$1.74B	$343.00M*	(m)	(m)	$404.00M*	(m)	(m)	(m)	$1.61B	$471.00M
2013-06-30	Reported	$2.04B*	$1.70B	$335.00M*	(m)	(m)	$394.00M*	(m)	(m)	(m)	$1.61B	$458.00M
2013-03-31	Reported	$1.98B	(m)	(m)	(m)	25.96%	$324.00M	(m)	(m)	(m)	$1.59B	$470.00M
2012-12-31	Reported	$1.78B	(m)	(m)	(m)	24.03%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	$2.00B*	$1.68B	$322.00M*	(m)	(m)	$358.00M*	(m)	(m)	(m)	$1.49B	$464.00M
2012-06-30	Reported	$2.05B*	$1.73B	$321.00M*	(m)	(m)	$358.00M*	(m)	(m)	(m)	$1.53B	$509.00M
2012-03-31	Reported	$1.95B	(m)	(m)	(m)	26.01%	$261.00M	(m)	(m)	(m)	$1.55B	$462.00M
2011-12-31	Reported	$1.68B	(m)	(m)	(m)	23.71%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	$1.89B*	$1.58B	$311.00M*	(m)	(m)	$336.00M*	(m)	(m)	(m)	$1.53B	$440.00M
2011-06-30	Reported	$1.97B*	$1.66B	$319.00M*	(m)	(m)	$295.00M*	$1.45B*	(m)	(m)	$1.58B	$437.00M
2011-03-31	Reported	$1.87B	(m)	(m)	(m)	25.54%	$231.00M	$733.00M	(m)	(m)	$1.53B	$442.00M
2010-12-31	Reported	$1.58B	(m)	(m)	(m)	23.61%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	$1.85B*	$1.58B	$278.00M*	(m)	(m)	$228.00M*	$1.32B*	(m)	(m)	$1.36B	$411.00M
2010-06-30	Reported	$1.87B*	$1.60B	$272.00M*	(m)	(m)	$180.00M*	$1.14B*	(m)	(m)	$1.35B	$414.00M
2010-03-31	Reported	$1.73B	(m)	(m)	(m)	27.28%	$157.00M	$1.08B	(m)	(m)	$1.32B	$448.00M
2009-12-31	Reported	$1.64B	(m)	(m)	(m)	26.79%	(m)	(m)	(m)	(m)	(m)	(m)
2009-09-30	Reported	$1.77B*	$1.48B	$290.00M*	(m)	(m)	$175.00M*	$1.74B*	(m)	(m)	$1.21B	$460.00M
2009-06-30	Reported	$1.49B*	$1.19B	$298.00M*	(m)	(m)	$210.00M*	$1.47B*	(m)	(m)	$1.24B	$351.00M
2009-03-31	Reported	$1.07B	(m)	(m)	(m)	21.10%	$244.00M	$695.00M	(m)	(m)	$1.19B	$229.00M
2008-09-30	Reported	(m)	$1.51B	(m)	(m)	(m)	$376.00M*	$1.17B*	(m)	(m)	$1.27B	$479.00M
2008-06-30	Reported	(m)	$1.45B	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$1.39B	$453.00M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$5.94B	(m)	(m)	(m)	23.80%	$910.00M	$2.31B	(m)	(m)	$4.00B	$1.00B
2024-12-31	Reported	$6.19B	(m)	(m)	(m)	25.17%	$1.18B	$1.82B	(m)	$700.00M	$4.22B	$804.00M
2023-12-31	Reported	-$8.7B	(m)	(m)	(m)	-35.36%	$1.61B	$6.68B	(m)	$700.00M	$19.20B	-$2.87B
2022-12-31	Reported	$6.2B	(m)	(m)	(m)	23.70%	$1.75B	$5.59B	(m)	$800.00M	$7.23B	$188.00M
2021-12-31	Reported	$9.28B	(m)	(m)	(m)	26.26%	$1.60B	$7.45B	(m)	$1.20B	$7.20B	$1.28B
2020-12-31	Reported	$9.07B	(m)	(m)	(m)	28.19%	$1.50B	$8.11B	(m)	$1.10B	$6.93B	$1.34B
2019-12-31	Reported	$7.77B	(m)	(m)	(m)	24.17%	$1.70B	$7.07B	(m)	$1.25B	$7.03B	$1.11B
2018-12-31	Reported	$8.7B	(m)	(m)	(m)	26.54%	$1.58B	$6.44B	(m)	$1.25B	$7.60B	$1.64B
2017-12-31	Reported	$9.24B	(m)	(m)	(m)	29.18%	$1.37B	$6.24B	(m)	$1.35B	$6.63B	$2.68B
2016-12-31	Reported	$8.5B	(m)	(m)	(m)	28.23%	$1.42B	$6.66B	(m)	$1.25B	$6.31B	$2.00B
2015-12-31	Reported	$8.38B	(m)	(m)	(m)	27.68%	$1.46B	$6.42B	(m)	$1.22B	$6.23B	$1.98B
2014-12-31	Reported	$8.54B	(m)	(m)	(m)	26.85%	$1.49B	(m)	(m)	$1.19B	$6.47B	$2.03B
2013-12-31	Reported	$8.04B	(m)	(m)	(m)	26.03%	$1.67B	(m)	(m)	$1.15B	$6.38B	$1.84B
2012-12-31	Reported	$7.77B	(m)	(m)	(m)	25.99%	$1.48B	(m)	(m)	$1.08B	$6.10B	$1.84B
2011-12-31	Reported	$7.41B	(m)	(m)	(m)	25.04%	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	$7.04B	(m)	(m)	(m)	26.40%	(m)	(m)	(m)	(m)	(m)	(m)
2009-12-31	Reported	$5.97B	(m)	(m)	(m)	25.82%	$903.00M	$4.94B	(m)	$838.00M	$4.91B	$1.39B
2008-12-31	Reported	$6.37B	(m)	(m)	(m)	25.21%	$1.47B	$4.53B	(m)	$851.00M	$5.25B	$1.59B
2007-12-31	Reported	$7.26B*	$6.19B	$1.07B	(m)	(m)	$1.42B	$4.25B	(m)	(m)	$5.01B	$1.96B

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
STRYKER CORP (SYK)	United States	$103.511B	32.39
BOSTON SCIENTIFIC CORP (BSX)	United States	$64.781B	17.29
BECTON DICKINSON & CO (BDX)	United States	$48.834B	43.79
DEXCOM INC (DXCM)	United States	$33.004B	25.42
WEST PHARMACEUTICAL SERVICES INC (WST)	United States	$26.288B	43.14
Solventum Corp (SOLV)	United States	$15.085B	9.16
Penumbra Inc (PEN)	United States	$12.596B	77.33
BAXTER INTERNATIONAL INC (BAX)	United States	$12.139B	-10.35
GLOBUS MEDICAL INC (GMED)	United States	$9.977B	20.03
INSULET CORP (PODD)	United States	$9.420B	28.12